This guideline covers the assessment and management of melanoma (a type of skin cancer) in children, young people and adults. It aims to reduce variation in practice and improve survival...
Bretonnière, C;
Leone, M;
Milési, C;
Allaouchiche, B;
Armand-Lefevre, L;
Baldesi, O;
Bouadma, L;
Decré, D;
Figueiredo, S;
Gauzit, R;
Guery, B;
Joram, N;
Jung, B;
Lasocki, S;
Lepape, A;
Lesage, F;
Pajot, O;
Philippart, F;
Souweine, B;
Tattevin, P;
Timsit, J. F;
Vialet, R;
Zahar, J. R;
Misset, B;
Bedos, J. P.
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimat...
Gosselin, S;
Morris, M;
Miller-Nesbitt, A;
Hoffman, R. S;
Hayes, B. D;
Turgeon, A. F;
Gilfix, B. M;
Grunbaum, A. M;
Bania, T. C;
Thomas, S. H;
Morais, J. A;
Graudins, A;
Bailey, B;
Mégarbane, B;
Calello, D. P;
Levine, M;
Stellpflug, S. J;
Hoegberg, L. C;
Chuang, R;
Stork, C;
Bhalla, A;
Rollins, C. J;
Lavergne, V.
Intravenous lipid emulsion (ILE) therapy is a novel treatment that was discovered in the last decade. Despite unclear understanding of its mechanisms of action, numerous and diverse publications attested to its clinical use. However, current evidence supporting its use is unclear and recommendations are ...
Yellow fever (YF) is a mosquito-borne viral disease that is endemic to sub-Saharan Africa and tropical South America. YF virus causes an estimated 200,000 cases of clinical disease and 30,000 deaths annually [WHO 1992]. Clinical disease ranges from a mild, undifferentiated febrile illness to severe disea...
In October 2014, the Food and Drug Administration (FDA) licensed the first serogroup B meningococcal (MenB) vaccine (MenB-FHbp [Trumenba®, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc., Philadelphia, Pennsylvania]) as a 3-dose series. The FDA licensed a second MenB vaccine (MenB-4C [Bexsero®...
This guideline covers diagnosing, assessing, managing and monitoring anaemia in people with chronic kidney disease. It aims to improve care for people with chronic kidney disease by specifying how to assess when their anaemia needs treating, and by making detailed recommendations on treatment with erythr...
This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help. In June 2015, we reviewed the evidence ...
This guideline covers diagnosing and managing bronchiolitis in children. It aims to help healthcare professionals diagnose bronchiolitis and identify if children should be cared for at home or in hospital. It describes treatments and interventions that can be used to help with the symptoms of bronchiolit...
OBJECTIVE: We sought to provide evidence-based guidelines for the diagnosis and management of fetal anemia. METHODS: A systematic literature review was performed using MEDLINE, PubMed, EMBASE, and the Cochrane Library. The search was restricted to English-language articles published from 1966 through May...
BACKGROUND: Non-melanoma skin cancer (NMSC), including basal and squamous cell carcinoma, represents the most common malignancy. OBJECTIVE: The aim of this document is to provide guidance to Canadian health care practitioners on NMSC management. METHODS: After conducting a literature review, the group d...